The CoIII—C bond in (1‐thia‐4,7‐diazacyclodecyl‐κ3N4,N7,C10)(1,4,7‐triazacyclononane‐κ3N1,N4,N7)cobalt(III) dithionate hydrate

In the title compound, [Co(C₆H₁₅N₃)(C₇H₁₅N₂S)]S₂O₆·H₂O, the Co—C bond distance is 1.9930 (13) Å, which is shorter than for related compounds with the linear 1,6‐di­amino‐3‐thia­hexan‐4‐ide anion in place of the macrocyclic 1‐thia‐4,7‐diazacyclo­decan‐8‐ide anion. The coordinated carbanion produces an elongation of 0.102 (7) Å of the Co—N bond to the 1,4,7‐tri­aza­cyclo­nonane N atom in the trans position. This relatively small trans influence is presumably a result of the tri­amine ligand forming strong bonds to the Co^III atom.     

The 1:1 adduct of Kemp's triacid with 2‐aminopyridine

The crystal structure determination of the molecular proton‐transfer adduct of Kemp's triacid (cis‐cis‐1,3,5‐tri­methyl­cyclo­hexane‐1,3,5‐tri­carboxylic acid, KTA) with 2‐amino­pyridine (2‐APY), namely 2‐amino­pyridinium 3,5‐di­carboxy‐1,3,5‐tri­methyl­cyclo­hexane­carboxyl­ate, 2‐APY⁺·KTA^? or C₅H₇N₂⁺·C₁₂H₁₇O₆^?, has revealed a centrosymmetric hydrogen‐bonded cyclic KTA homodimer repeating unit [O?O 2.524 (4) Å] linked into a polymer structure through the pyridinium and amino groups of the 2‐APY mol­ecule [O?N 2.736 (4), 2.989 (4) and 2.999 (4) Å].     

Precursor of a β‐lactamase inhibitor: allyl (4S,8S,9R)‐10‐[(E)‐ethyl­idene]‐4‐methoxy‐11‐oxo‐1‐aza­tri­cyclo­[7.2.0.03,8]­undec‐2‐ene‐2‐carboxyl­ate

The molecular structure of the title tricyclic compound, C₁₇H₂₁NO₄, which is the immediate precursor of a potent synthetic inhibitor {Lek157: sodium (8S,9R)‐10‐[(E)‐ethyl­idene]‐4‐methoxy‐11‐oxo‐1‐aza­tri­cyclo­[7.2.0.0^3,8]­undec‐2‐ene‐2‐carboxyl­ate} with remarkable potency, provides experimental evidence for the previously modelled relative position of the fused cyclo­hexyl ring and the carbonyl group of the β‐lactam ring, which takes part in the formation of the initial tetrahedral acyl–enzyme complex. In this hydro­phobic mol­ecule, the overall geometry is influenced by C—H?O intramolecular hydrogen bonds [3.046 (4) and 3.538 (6) Å, with corresponding normalized H?O distances of 2.30 and 2.46 Å], whereas the mol­ecules are interconnected through intermolecular C—H?O hydrogen bonds [3.335 (4)–3.575 (5) Å].     

N‐Ethylazatribenzo‐21‐crown‐7

The structure of the title compound, 25‐ethyl‐2,5,12,15,22,28‐hexa­oxa‐25‐aza­tetra­cyclo­[27.4.0.0^6,11.0^16,21]­tri­tria­conta‐1(29),6(11),7,9,16(21),17,19,30,32‐nona­ene, C₂₈H₃₃NO₆, does not exhibit a binding cavity for cations, but is collapsed in on itself. The conformation is unique among known tri­benzo‐21‐crown‐7 structures, and may be a result of intermolecular (C—H?π) and intramolecular (C—H?O) hydrogen bonding.     

[1,5‐Bis(1‐methyl‐1H‐imidazol‐2‐yl­methyl‐κN3)‐1,5‐di­aza­cyclo­octane‐N,N′]chlorocobalt(II) perchlorate

The crystal structure of the title compound, [CoCl‐(C₁₆H₂₆N₆)]ClO₄, consists of discrete [CoCl­(C₁₆­H₂₆N₆)]⁺ cations and perchlorate anions. The five‐coordinate Co^II atom has four nitro­gen donors from the new mesocyclic ligand 1,5‐bis(1‐methyl‐1H‐­imidazol‐2‐ylmethyl)‐1,5‐di­aza­cyclo­octane [Co—N 2.046 (3)–2.214 (4) Å], and a chloride anion at the apical site [Co—Cl 2.3184 (13) Å]. The coordination geometry of the complex is essentially square pyramidal. The mesocyclic ligand takes a boat–chair configuration and the two imidazole pendants are not coplanar. The dihedral angle between the two imidazole planes is 15.97°. An H atom from the 1,5‐diaza­cyclo­octane group effectively blocks the axial coordination site opposite the Cl ligand.     

Difur­aza­no­[3,4‐b:3′,4′‐f]‐4,5‐di­aza‐1,8‐dioxa­cyclo­dodecine and an acyclic analogue

The novel title fur­azan‐containing macrocycle (systematic name: 6,9,14,17‐tetraoxa‐2,3,5,7,16,18‐hexa­aza­tri­cyclo­[13.3.0.0^4,8]­octadeca‐4,7,15,18‐tetraene), C₈H₁₀N₆O₄, (I), is the first macrocycle where the fur­azan rings are connected via a hydrazine group. In spite of the strain in the 12‐membered macrocycle of (I), the geometry of the fur­azan fragment is the same in (I) and in its acyclic analogue 1,8‐bis(5‐amino­fur­azan‐4‐yl­oxy)‐3,6‐dioxaoctane, C₁₀H₁₆N₆O₆, (II). In both compounds, the participation of the fur­azan rings in intermolecular hydrogen bonding equalizes the N—O bonds within the fur­azan rings, in contrast with rings which do not participate in such interactions.     

1,2,4‐Triazolo­[2,3‐h]‐7,9‐thi­aza‐11‐crown‐4

The title compound, 4,7‐dioxa‐10‐thia‐1,12,13‐tri­aza­bi­cyclo­[9.3.0]­tetra­deca‐11,13‐diene, C₈H₁₃N₃O₂S, contains an 11‐membered ring, which appears in a chair conformation and has approximate mirror symmetry. It may be used for the complexation of metal atoms.     

NiII and ZnII complexes of the hexadentate macrocyclic ligand cis‐6,13‐di­methyl‐1,4,8,11‐tetra­aza­cyclo­tetra­decane‐6,13‐di­amine

The title pendent‐arm macrocyclic hexa­amine ligand binds stereospecifically in a hexadentate manner, and we report here its isomorphous Ni^II and Zn^II complexes (both as perchlorate salts), namely (cis‐6,13‐di­methyl‐1,4,8,11‐tetra­aza­cyclo­tetra­decane‐6,13‐di­amine‐κ⁶N)­nickel(II) di­per­chlorate, [Ni(C₁₂H₃₀N₆)]­­(ClO₄)₂, and (cis‐6,13‐di­methyl‐1,4,8,11‐tetraaza‐cyclo­tetra­decane‐6,13‐di­amine‐κ⁶N)­zinc(II) di­per­chlorate, [Zn(C₁₂H₃₀N₆)]­(ClO₄)₂. Distortion of the N—M—N valence angles from their ideal octahedral values becomes more pronounced with increasing metal‐ion size and the present results are compared with other structures of this ligand.     

A novel bridged asymmetric binuclear manganese(II) complex with DTPB [DTPB is 1,1,4,7,7‐pentakis(1H‐benz­imidazol‐2‐yl­methyl)‐1,4,7‐tri­aza­heptane]

The crystal structure of the title compound, tetra­chloro­[μ‐1,1,4,7,7‐pentakis(1H‐benzimidazol‐2‐yl­methyl)‐1,4,7‐tri­azaheptane]­dimanganese(II) methanol pentasolvate tetrahydrate, [Mn₂Cl₄(C₄₄H₄₃N₁₃)]·5CH₄O·4H₂O, contains an ­asymmetric dinuclear Mn^II–DTPB [DTPB is 1,1,4,7,7‐pentakis(1H‐benzimidazol‐2‐yl­methyl)‐1,4,7‐tri­aza­heptane] complex with an intra‐ligand bridging group (–NCH₂CH₂N–), as well as several solvate mol­ecules (methanol and water). Both Mn^II cations have similar distorted octahedral coordination geometries. One Mn^II cation is coordinated by a Cl⁻ anion and five N atoms from the ligand, and the other is coordinated by three Cl⁻ anions and three N atoms of the same ligand. The Mn⋯Mn distance is 7.94 Å. A Cl⋯H—O⋯H—O⋯H—N hydrogen‐bond chain is also observed, connecting the two parts of the complex.     

[N,N′‐Bis(3‐aminopropyl)ethylenediamine‐κ4N,N′,N′′,N′′′](trithiocyanurato‐κ2N,S)zinc(II) ethanol solvate

In the crystal structure of the title compound, [N,N′‐bis(3‐­amino­propyl)­ethyl­enedi­amine‐κ⁴N,N′,N′′,N′′′][1,3,5‐triazine‐2,4,6(1H,3H,5H)‐tri­thionato(2−)‐κ²N,S]­zinc(II) ethanol sol­vate, [Zn(C₈H₂₂N₄)₂(C₃HN₃S₃)]·C₂H₆O, the Zn^II atom is octa­hedrally coordinated by four N atoms [Zn—N = 2.104 (2)–2.203 (2) Å] of a tetradentate N‐donor N,N′‐bis(3‐­amino­propyl)­ethyl­enedi­amine (bapen) ligand and by two S and N atoms [Zn—S = 2.5700 (7) Å and Zn—N = 2.313 (2) Å] of a tri­thio­cyanurate(2−) (ttcH²⁻) dianion bonded as a bidentate ligand in a cis configuration. The crystal structure of the compound is stabilized by a network of hydrogen bonds.     

The NiII,HgII and CuII complexes of 12‐membered‐ring mixed‐donor macrocycles

The structures of di­aqua(1,7‐dioxa‐4‐thia‐10‐aza­cyclo­do­decane)­nickel dinitrate, [Ni(C₈H₁₇NO₂S)(H₂O)₂](NO₃)₂, (I), bis­(nitrato‐O,O′)(1,4,7‐trioxa‐10‐aza­cyclo­do­decane)­mercury, [Hg(NO₃)₂(C₈H₁₇NO₃)], (II), and aqua­(nitrato‐O)(1‐oxa‐4,7,10‐tri­aza­cyclo­do­decane)copper nitrate, [Cu(NO₃)(C₈H₁₉N₃O)(H₂O)]NO₃, (III), reveal each macrocycle binding in a tetradentate manner. The conformations of the ligands in (I) and (III) are the same and distinct from that identified for (II). These differences are in agreement with molecular‐mechanics predictions of ligand conformation as a function of metal‐ion size.     

Bis{μ‐2‐[(1,5‐diaza‐1‐cyclooctyl)methyl]phenolato‐N,N′,O:O}bis[chlorozinc(II)] diacetone solvate: design of a square‐pyramidal ZnN2O2Cl complex

The title complex, [Zn₂(C₁₃H₁₉N₂O)₂Cl₂]·2C₃H₆O, resides on a crystallographic inversion center. The two Zn^II centers bridged by the phenoxo groups are in pentacoordinated distorted square‐pyramidal coordination environments with an intramolecular Zn?Zn distance of 3.175 (3) Å. The mesocyclic ligand takes a boat–chair conformation and an H atom from the 1,5‐di­aza­cyclo­octane ring effectively blocks the axial coordination site opposite the Cl ligand to form the ZnN₂O₂Cl geometry. The crystal structure is stabilized by a N—H?O hydrogen bond between the amino group and an acetone mol­ecule.     

Chloro(2‐{[5‐(2‐hydroxy­benzyl‐O)‐1,5‐di­aza‐1‐cyclo­octyl‐N,N′]­methyl}phenolato‐O)­cadmium(II)

The crystal structure of the title complex, [Cd(C₂₀H₂₅­N₂­O₂)­Cl], reveals a hydrogen‐bonded dimer composed of neutral molecules. The Cd^II center is five‐coordinated by two O atoms of the pendant arms, two nitro­gen donors of the 1,5‐di­aza­cyclo­octane ring and a chloride anion. The coordination geometry of the complex could be described as a distorted square pyramid. The 1,5‐di­aza­cyclo­octane backbone adopts a boat/chair configuration and the two phenol/phenolato groups have a dihedral angle of 101.3 (2)° between them. The coordinated phenolate and phenolic groups of inversion‐related mol­ecules form strong intermolecular O—H?O hydrogen bonds.     

Two new soluble iron–oxo complexes: [Fe2(μ‐O)(μ‐O2CCF3)2(O2CCF3)2(C10H8N2)2] and [Fe4(μ3‐O)2(μ‐O2CCF3)6(O2CCF3)2(C10H8N2)2]·CF3CO2H

Two new iron–oxo clusters, viz. di‐μ‐tri­fluoro­acetato‐μ‐oxo‐bis­[(2,2′‐bi­pyridine‐κ²N,N′)(tri­fluoro­acetato‐κO)­iron(III)], [Fe₂O(CF₃CO₂)₄(C₁₀H₈N₂)₂], and bis(2,2′‐bi­pyridine)­di‐μ₃‐oxo‐hexa‐μ‐tri­fluoro­acetato‐bis­(tri­fluoro­acetato)­tetrairon(III) tri­fluoro­acetic acid solvate, [Fe₄O₂(CF₃CO₂)₈(C₁₀H₈N₂)₂]·CF₃CO₂H, contain dinuclear and tetranuclear Fe^III cores, respectively. The Fe^III atoms are in distorted octahedral environments in both compounds and are linked by oxide and tri­fluoro­acetate ions. The tri­fluoro­acetate ions are either bridging (bidentate) or coordinated to the Fe^III atoms via one O atom only. The fluorinated peripheries enhance the solubility of these compounds. Formal charges for all the Fe centers were assigned by summing valences of the chemical bonds to the Fe^III atom.     

catena‐Poly[[[cis‐aqua­bis(4‐carboxy­cyclo­hexane‐1‐carboxyl­ato‐κ2O,O′)cadmium(II)]‐μ‐4,4′‐bipyridine‐κ2N:N] monohydrate]

The title complex, {[Cd(C₈H₁₁O₄)₂(C₁₀H₈N₂)(H₂O)]·H₂O}_n, consists of linear chains formed through 4,4′‐bipyridine ligands linking seven‐coordinated Cd^II ions. Each Cd^II ion is in a distorted penta­gonal–bipyramidal environment, coordinated by one water ligand, two 4‐carboxy­cyclo­hexane‐1‐carboxyl­ate ligands and one bridging 4,4′‐bipyridine ligand to generate linear chains. The water mol­ecules and the Cd atom on one side, and the 4,4′‐bipyridine unit on the other, are bisected by two sets of twofold axes. The carboxylate group of the 4‐carboxy­cyclo­hexane‐1‐carboxyl ligand chelates a Cd^II ion, while the (protonated) carboxyl group forms hydrogen bonds with adjacent chains, resulting in a layered structure. This is the first reported occurrence of a dicarboxycyclo­hexane ligand exhibiting a non‐bridging coordination mode.     

Intramolecular cyclization of 4,7‐bis(2‐bromo­acetyl)‐1‐thia‐4,7‐di­azacyclo­nonane

The reaction of 1‐thia‐4,7‐di­azacyclo­nonane with bromo­acetyl bromide in CHCl₃ affords the unexpected salt 4‐(2‐bromo­acetyl)‐8‐oxo‐1‐thionia‐4,7‐di­aza­bi­cyclo­[5.2.2]­un­decane bromide, C₁₀H₁₆BrN₂O₂S⁺·Br⁻. Two units of the salt are linked by S⋯Br contacts about a crystallographic inversion centre, thus forming dimers that are linked by Br⋯Br contacts into extended ribbons. S⋯O contacts between these ribbons generate a two‐dimensional sheet.     

(μ‐C‐meso‐5,5,7,12,12,14‐Hexa­methyl‐1,4,8,11‐tetra­aza­cyclo­tetra­decane‐N‐acetato‐1κ5N,N′,N′′,N′′′,O:2κO′)­tetra­chloro‐1κCl,2κ3Cl‐cobalt(III)­zinc(II)

The crystal structure of the title compound, [CoCl(C₁₈H₃₇N₄O₂){ZnCl₃}], has been determined by X‐ray diffraction.C‐meso‐5,5,7,12,12,14‐Hexa­methyl‐1,4,8,11‐tetra­aza­cyclotetradecane‐N‐acetate acts as a bridging ligand to coodinate with Co^III and Zn^II ions. The Co^III ion is six‐coordinate in a nearly octahedral environment provided by one Cl atom, four N atoms of the bridging ligand, and one O atom. The Zn^II ion is four‐coordinate in a distorted tetrahedral environment completed by three Cl atoms and an O atom of the bridging ligand.     

2‐{[Tris(hydroxymethyl)methyl]aminomethylene}cyclohexa‐3,5‐dien‐1(2H)‐one and its 6‐hydroxy and 6‐methoxy derivatives

The title compounds, 2‐{[tris­(hydroxy­methyl)­methyl]­amino­methyl­ene}cyclo­hexa‐3,5‐dien‐1(2H)‐one, C₁₁H₁₅NO₄, (I), 6‐hydroxy‐2‐{[tris­(hydroxy­methyl)­methyl]­amino­methyl­ene}­cyclo­hexa‐3,5‐dien‐1(2H)‐one, C₁₁H₁₅NO₅, (II), and 6‐methoxy‐2‐{[tris­(hydroxy­methyl)­methyl]­amino­methyl­ene}­cyclo­hexa‐3,5‐dien‐1(2H)‐one, C₁₂H₁₇NO₅, (III), adopt the keto–amine tautomeric form, with the formal hydroxy H atom located on the N atom, and the NH group and oxo O atom display a strong intramolecular N—H⋯O hydrogen bond. The N—H⋯O hydrogen‐bonded rings are almost planar and coupled with the cyclo­hexa­diene rings. The carbonyl O atoms accept two other H atoms from the alcohol groups of adjacent mol­ecules in (I), and one from the alcohol and one from the phenol group in (II), but from only one alcohol H atom in (III).     

Polymeric di­aqua­bis­[μ4‐1,3,5‐benzenetri­carboxyl­ato(3–)](μ‐4,4′‐bi­pyridine)­trizinc(II)

The solvothermal reaction of zinc(II) acetate with 1,3,5‐benzene­tri­carboxyl­ic acid and 4,4′‐bi­pyridine in 1‐butanol and acetic acid solution gives the title complex, [Zn₃(C₉H₃O₆)₂(C₁₀H₈N₂)(H₂O)₂]_n. There are two different coordination environments for the Zn atom, namely ZnNO₂(H₂O) and ZnO₄; in the latter case, the Zn atom lies on a twofold symmetry axis. Carboxyl­ate‐bridged Zn₃(O₂C)₆ clusters are connected through 1,3,5‐benzene­tri­carboxyl­ate and 4,4′‐bi­pyridine ligands (which lie about inversion centers), yielding a three‐dimensional framework.     

Λ‐{1,4,7,10‐Tetrakis­[(S)‐2‐hydroxy­propyl‐κO]‐1,4,7,10‐tetra­aza­cyclo­do­decane‐κ4N}cadmium(II) bis(2,4,6‐tri­nitro­phenolate) aceto­nitrile solvate

Crystallization of [Cd(S‐thpc12)](ClO₄)₂·H₂O {S‐thpc12 is 1,4,7,10‐tetrakis­[(S)‐2‐hydroxy­propyl]‐1,4,7,10‐tetra­aza­cyclo­do­decane} in the presence of two equivalents of sodium picrate monohydrate (sodium 2,4,6‐tri­nitro­phenolate monohydrate) diastereoselectively produces a neutral receptor complex, viz. the title compound, Λ‐[Cd(C₂₀H₄₄N₄O₄)](C₆H₂N₃O₇)₂·CH₃CN. In this complex, two picrate anions hydrogen bond, via their phenolate moieties, to the pendant hydroxyl groups of the receptor which, together with the four N atoms, themselves bond to Cd^II in an approximately cubic arrangement. One picrate anion hydrogen bonds to all four hydroxyl groups, one of which also acts as the sole hydrogen‐bond donor to the second picrate anion.